Possible drawbacks of relying only on molecular testing for diagnosing SARS-CoV-2 infections
Public Health
.
2022 Apr:205:e2.
doi: 10.1016/j.puhe.2021.09.035.
Epub 2021 Oct 5.
Authors
G Lippi
1
,
B M Henry
2
Affiliations
1
Section of Clinical Biochemistry, University of Verona, Verona, Italy. Electronic address: giuseppe.lippi@univr.it.
2
Clinical Laboratory, Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
PMID:
34756587
PMCID:
PMC8491921
DOI:
10.1016/j.puhe.2021.09.035
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19* / diagnosis
Humans
Molecular Diagnostic Techniques
SARS-CoV-2